Usefulness of soluble ICAM-1 measurements for evaluation the disease activity and efficiency of therapy in patients with infiltrative Graves' ophthalmopathy;Przydatność oznaczeń rozpuszczalnej formy cza̧steczki adhezyjnej ICAM-1 do oceny aktywności choroby i efektów leczenia obrzȩkowo-naciekowej postaci oftalmopatii tarczycowej w przebiegu choroby Gravesa i basedowa

Polskie Archiwum Medycyny Wewnetrznej

Volumn 108, Issue 6, 2002, Pages 1161-1169

  Kulig, Grzegorz ^a   Pilarska, Krstyna ^a   Kulig, Jolanta ^a   Krzyzanowska Świniarska, Barbara ^a   Robaczyk, Maciej ^a   Baraniak, Artur ^a  

^a NONE

Author keywords

Adhesion molecules; Graves' disease; Thyroid ophthalmopathy

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE EXACERBATION; ENDOCRINE OPHTHALMOPATHY; FEMALE; GRAVES DISEASE; HUMAN; MALE; PROTEIN BLOOD LEVEL;

EID: 0036947405     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Heufelder A.E., Bahn R.S.: Elevated expression in situ of selectin and immunoglobulin superfamily type adhesion molecules in retroocular connective tissues from patients with Graves' ophthalmopathy. Clin. Exp. Immunol., 1993, 91, 381.
2. Marazuela M., Postigo A., Acevedo A., Federico G., Francisco S., M., Manuel O.L.: Adhesion molecules from the LFA-1/ICAM-1,3 and VLA-4/ VCAM-1 pathways on T lymphocytes and vascular endothelium in Graves' and Hashimoto's thyroid glands. Eur. J. Immunol., 1994, 24, 2483.
3. Heufelder A.E., Bahn R.S.: Soluble intercellular adhesion molecule-1 (sICAM-1) in sera of patients with Graves' ophthalmopathy and thyroid diseases. Clin. Exp. Immunol., 1993, 92, 296.
4. Wenisch C., Myskiw A., Gessl A., Graniger W.: Circulating selectins, intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in hyperthyroidism. J. Clin. Endocrinol. Metab. 1995, 80, 2122.
5. De Bellis A., Di Martino S., Fiordelisi F. i wsp.: Soluble intercellular adhesion molecule-1 (sICAM-1) concentrations in Graves' disease patients followed up for development of ophthalmopathy. J. Clin. Endocrinol. Metab. 1998, 83, 1222.
6. Bartalena L., Marocci C., Chiovato L. i wsp.: Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone. J. Clin. Endocrinol. Metab., 1983, 58, 1139.
7. Werner S.C.: Modification of the classification of the eye changes of Graves' disease: recommendations of the ad hoc Committee of the American Thyroid Association. J. Clin. Endocrinol. Metab., 1977, 1, 203.
8. Donaldson S.S., Bagshaw M.A., Kriss J.P.: Supervoltage orbital radiotherapy for Graves' ophthalmopathy. J. Clin. Endocrinol. Metab., 1976, 118, 276.
9. Ciampolillo A., Napolitano G., Mirakian R., Miyasaki A., Giorgino R.: Intercelular adhesion molecule-1 (ICAM-1) in Graves' disease: contrast between in vivo and in vitro results. Clin. Exp. Immunol., 1993, 94, 478.
10. Kahaly G., Hansen CH., Felke B., Dienes H.P.: Immunohistochemical staining of retrobulbar adipose tissue in Graves' ophthalmopathy. Clin. Immunol. Immunopathol., 1994, 1, 53.
11. Miyazaki A., Mirakian R., Bottazzo F.: Adhesion molecule expression in Graves' thyroid glands; potential relevance of granule membrane protein (GMP-140) and intercellular adhesion molecule-1 (ICAM-1) in the homing and antigen presentation processes. Clin. Exp. Immunol., 1992, 89, 52.
12. Tolosa E., Roura C., Catalfamo M., Marti M., Lucas-Martin A.: Expression of intercellular adhesion molecule-1 in thyroid follicular cells in autoimmune, non-autoimmune and neoplastic diseases of thyroid gland: Discordance with HLA. J. Autoimmunity, 1992, 5, 107.
13. Weetman A.P., Cohen S., Makgoba M.W., Borysiewicz L.K.: Expression of an intercellular adhesion molecule ICAM-1 by human thyroid cells. J. Endocrinol., 1989, 122, 185.
14. Balazs Cs., Kiss E.: Soluble intercellular adhesion molecule-1 (sICAM-1) in Graves' disease. Acta Microbiol. Immunol. Hung., 1994, 41, 451.
15. Ozata M., Bolu E., Sengul A. i wsp.: Soluble intercellular adhesion molecule-1 concentrations with subacute thyroiditis and in patients with Graves' disease with or without ophthalmopathy. Endocr. J. 1996, 43, 517.
16. Sonnet E., Massart C., Gibassier J., Allannic H., Mougendre D.: Longitudinal study of soluble intercellular adhesion molecule-1 (ICAM-1) in sera of patients with Graves' disease. J. Endocr. Onvest., 1999, 22, 430.
17. Myśliwiec J., Krȩtowski A., Szelachowska M., Mikita A., Kinalska I.: Ocena stȩżeń selektyny L oraz ICAM-1 w surowicy chorych z choroba̧ Gravesa i Basedowa bez oftalmopatii i podczas leczenia oftalmopatii kortykosteroidami. Endokrynol. Pol., 1999, 3 (suppl. 1), s.117.
18. Modelska A., Gembicki M., Bednarek J., Sowiński J.: Wpływ kortykoterapii na stȩżenia rozpuszczalnych form cza̧steczek adhezyjnych w surowicy pacjentów z oftalmopatia, naciekowa̧, w przebiegu choroby Graves-Basedowa. Endokrynol. Pol., 1999, 3 (suppl. 1) 115.